Immune-Related Adverse Events of Immune Checkpoint Inhibitors

Authors

Charoo Iyer, Rochester Regional HealthFollow
Chengu Niu, Rochester Regional HealthFollow
Ido Goldenberg, Rochester Regional HealthFollow
Mehul Patel, Rochester Regional HealthFollow

Document Type

Presentation

Department

Internal Medicine

Additional Department

Oncology and Hematology

Abstract

Immune-Related Adverse Events of Immune Checkpoint Inhibitors. Charoo Iyer, Chief Resident, Rochester General Hospital Internal Medicine Residency Program; Chengu Niu, Chief Resident, Rochester General Hospital Internal Medicine Residency Program; Ido Goldenberg, Chief Resident, Rochester General Hospital Internal Medicine Residency Program; Mehul Patel, MD, RRH Hematology/Oncology, Lipson Cancer Institute

Objectives:

• Discuss Immune Related Adverse events (irAEs)
• Explain why irAEs occur
• Cite why we need to know about irAEs
• Describe management of irAEs, with focus on: Colitis-Hepatitis-Pneumonitis-Endocrinopathies

Publication Date

4-18-2024

Comments

00:01:37 Immune-Related Adverse Events of Immune Checkpoint Inhibitors

Recommended Citation

Iyer, C., Niu, C., Goldenberg, I., & Patel, M. (2024). Immune-Related Adverse Events of Immune Checkpoint Inhibitors. Retrieved from https://scholar.rochesterregional.org/grandrounds_rgh/120